Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
9.73
-0.20 (-1.97%)
At close: Sep 10, 2025, 4:00 PM
9.67
-0.05 (-0.53%)
After-hours: Sep 10, 2025, 6:15 PM EDT
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of $1.14 billion as of September 10, 2025. Its market cap has decreased by -22.85% in one year.
Market Cap
1.14B
Enterprise Value
825.64M
1-Year Change
-22.85%
Ranking
Category
Stock Price
$9.73
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from $222.50M to $1.14B, an increase of 412.55%. That is a compound annual growth rate of 7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 1.16B | -30.70% |
| Dec 31, 2024 | 1.68B | -7.11% |
| Dec 29, 2023 | 1.81B | 33.12% |
| Dec 30, 2022 | 1.36B | -19.57% |
| Dec 31, 2021 | 1.69B | 244.22% |
| Dec 31, 2020 | 490.30M | 2.21% |
| Dec 31, 2019 | 479.70M | -16.37% |
| Dec 31, 2018 | 573.60M | -49.38% |
| Dec 29, 2017 | 1.13B | 644.48% |
| Dec 30, 2016 | 152.20M | -83.61% |
| Dec 31, 2015 | 928.40M | 109.43% |
| Dec 31, 2014 | 443.30M | -13.87% |
| Dec 31, 2013 | 514.70M | 1.06% |
| Dec 31, 2012 | 509.30M | 20.97% |
| Dec 30, 2011 | 421.00M | 13.85% |
| Dec 31, 2010 | 369.80M | 531.06% |
| Dec 31, 2009 | 58.60M | 74.93% |
| Dec 31, 2008 | 33.50M | -83.51% |
| Dec 31, 2007 | 203.20M | -41.66% |
| Dec 29, 2006 | 348.30M | 177.97% |
| Dec 30, 2005 | 125.30M | -36.40% |
| Dec 31, 2004 | 197.00M | -11.46% |
| Feb 19, 2004 | 222.50M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |